You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

squamous cell cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Cell Cancer, Squamous Cell Carcinoma, Skin Cancer Trial in Boise (30% ascorbic acid in DMSO)

Recruiting
  • Squamous Cell Cancer
  • +3 more
  • 30% ascorbic acid in DMSO
  • Boise, Idaho
    Center for Biomedical Research,Inc.
Jul 2, 2023

Esophageal Squamous Cell Carcinomas, Concurrent Chemoradiotherapy, Immunotherapy Trial (chemo combined with PD-1 inhibitors)

Not yet recruiting
  • Esophageal Squamous Cell Carcinomas
  • +3 more
  • chemotherapy combined with PD-1 inhibitors
  • (no location specified)
Nov 17, 2022

Head and Neck Squamous Cell Cancer Trial in Shanghai (Toripalimab Injection, Cetuximab Solution for infusion)

Recruiting
  • Head and Neck Squamous Cell Cancer
  • Toripalimab Injection
  • Cetuximab Solution for infusion
  • Shanghai, China
    Shanghai East Hospital
Dec 15, 2022

Esophageal Squamous Cell Cancer Trial in Beijing (Toripalimab, Paclitaxel, Cisplatin)

Recruiting
  • Esophageal Squamous Cell Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023

Head and Neck Squamous Cell Cancer

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • OncoPrism-HNSCC™
  • San Francisco, California
    Curebase
Sep 7, 2022

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Penpulimab Combined With CRT)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Penpulimab Combined With CRT
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Sep 28, 2022

Head and Neck Squamous Cell Cancer, Recurrent Head and Neck Squamous Cell Cancer, Metastatic Head and Neck Squamous Cell Cancer

Active, not recruiting
  • Head and Neck Squamous Cell Cancer
  • +2 more
  • Miami, Florida
  • +8 more
Dec 2, 2022

Vulva Cancer, Vulva Tumor, Squamous Cell Cancer Trial (Pembrolizumab)

Not yet recruiting
  • Vulva Cancer
  • +2 more
  • (no location specified)
Mar 7, 2023

Recurrent Head and Neck Squamous Cell Carcinoma Trial in Atlanta, Cleveland, Milwaukee (IMRT, Nivolumab)

Active, not recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • IMRT
  • Nivolumab
  • Atlanta, Georgia
  • +3 more
Jan 10, 2023

Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Malignant Solid Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Head and Neck Squamous Cell Cancer Trial in London (BYL719)

Active, not recruiting
  • Head and Neck Squamous Cell Cancer
  • London, Ontario, Canada
    London Health Sciences Centre, London Regional Cancer Program
Jun 14, 2022

Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma Trial in Guangzhou

Recruiting
  • Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
  • Tucidinostat (chidamide) and PD-1 inhibitor （Toripalimab）
  • Guangzhou, Guangdong, China
    Cancer center of Sun Yat-sen University
Jul 20, 2022

Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and

Recruiting
  • Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • +4 more
  • Cemiplimab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 17, 2023

Cutaneous Squamous Cell Carcinoma, Skin Cancers - Squamous Cell Carcinoma Trial in Pittsburgh (Microneedle Array Doxorubicin

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Skin Cancers - Squamous Cell Carcinoma
  • Microneedle Array Doxorubicin (MNA-D)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Nov 28, 2022

Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

Active, not recruiting
Has Results
  • Squamous Cell Carcinoma of the Oropharynx
  • +7 more
  • Tampa, Florida
  • +2 more
Dec 30, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Cleveland (Pembrolizumab, IMRT 60-66Gy)

Completed
Has Results
  • Squamous Cell Carcinoma of the Head and Neck
  • Cleveland, Ohio
  • +1 more
Jun 29, 2022

Minimally Residual of Esophageal Cancer 001

Recruiting
  • Esophageal Carcinoma
  • Minimal Residual Disease
    • Shijiazhuang, Hebei, China
      Fourth Hospital of Hebei Medical University
    Jul 17, 2023

    Stage IV Esophagus Squamous Cell Carcinoma Trial in Hangzhou (Camrelizumab, Irinotecan, Paclitaxel)

    Not yet recruiting
    • Stage IV Esophagus Squamous Cell Carcinoma
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Apr 2, 2022

    Head and Neck Squamous Cell Cancer Trial (pembrolizumab, methotrexate, docetaxel)

    Completed
    Has Results
    • Head and Neck Squamous Cell Cancer
    • pembrolizumab
    • +3 more
    • (no location specified)
    Aug 24, 2022

    Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8

    Not yet recruiting
    • Oral Cavity Squamous Cell Carcinoma
    • +4 more
    • Near Infrared Imaging
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 5, 2022

    Immunotherapy;Envafolimab; Esophageal Cancer Trial (Envafolimab, Abraxane, Cisplatin)

    Not yet recruiting
    • Immunotherapy;Envafolimab; Esophageal Cancer
    • (no location specified)
    Apr 24, 2023

    Squamous Cell Carcinoma of the Head and Neck Trial in La Jolla, San Francisco, Torrance (Pembrolizumab)

    Active, not recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • La Jolla, California
    • +2 more
    Aug 17, 2022

    Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +23 more
    • Biospecimen Collection
    • +2 more
    • Los Angeles, California
    • +1 more
    Jul 7, 2022

    Squamous Cell Carcinoma, Skin Cancer, Keratoacanthoma Trial in Scottsdale, Tucson (Injection of TVEC into target lesions - week

    Recruiting
    • Squamous Cell Carcinoma
    • +5 more
    • Injection of TVEC into target lesions - week 1-2
    • +3 more
    • Scottsdale, Arizona
    • +1 more
    Apr 6, 2022

    Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous

    Active, not recruiting
    • Metastatic Head and Neck Squamous Cell Carcinoma
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 27, 2022